Skip to Content
Biotechnology and health

CRISPR experts are calling for a global moratorium on heritable gene editing

Some of the biggest names in gene editing want to stop anyone from playing around with cells that pass on changes to the next generation.
March 13, 2019

After the first International Summit on Human Gene Editing in December 2015, a statement was released. The organizers were unanimous in agreeing that the creation of genetically modified children was “irresponsible” unless we knew for sure it was safe.

Well, a fat lot of good that did. As was revealed in November last year, Chinese scientist He Jiankui edited embryos to create two genetically engineered babies. Other groups are now actively looking to use the technology to enhance humans.

This has prompted some of the biggest names in gene editing (some of whom signed the 2015 statement) to call for a global moratorium on all human germline editing—editing sperm or egg cells so that the changes are hereditary.

In an open letter in Nature this week, major players in CRISPR’s development, including Emmanuelle Charpentier, Eric Lander, and Feng Zhang, have been joined by colleagues from seven different countries to call for a total ban on human germline editing until an international framework has been agreed on how it should be treated. They suggest five years "might be appropriate." The US National Institutes of Health has also backed the call.

The signatories hope a voluntary global moratorium will stop the next He Jiankui from suddenly springing another unwelcome surprise.

The group says that this moratorium period will allow time to discuss the “technical, scientific, medical, societal, ethical, and moral issues that must be considered” before the technique can be used. Countries that decide to go ahead and allow germline editing should do so only after notifying the public of the plan, engaging in international consultation “about the wisdom of doing so,” and making sure that there is a “broad societal consensus” in the country for starting on that path, they say.

“The world might conclude that the clinical use of germline editing is a line that should not be crossed for any purpose whatsoever,” the group says. “Alternatively, some societies might support genetic correction for cou­ples with no other way to have biologically related children, but draw a line at all forms of genetic enhancement. Or, societies could one day endorse limited or widespread use of enhancement.”

The letter’s signatories suggest that germline research should be allowed so long as there is no intention to implant embryos and produce children. Using CRISPR to treat diseases in non-reproductive somatic cells (where the changes would not be heritable) should also be fine so long as any adults participating have given their informed consent. Genetic enhancement should not be allowed at this time, and no clinical application carried out unless its “long-­term biologi­cal consequences are sufficiently understood—both for individuals and for the human species,” they write.

We still don’t know what the majority of our genes do, so the risks of unintended consequences or so-called off-target effects—good or bad—are huge. The loss of the CCR5 gene that He was targeting to protect children from HIV, for example, has been implicated in increased complications and death from some viral infections.

Changes in a genome might have unforeseen outcomes in future generations as well. “Attempting to reshape the species on the basis of our current state of knowledge would be hubris,” the letter reads.

The proposed moratorium and global framework are only voluntary— and unlikely to stop rogue scientists. But the signatories feel an outright ban and regulation would be too “rigid.” Instead, they hope their proposal will “place major speed bumps in front of the most adventurous plans to re­engineer the human species.”

Indeed, chastened by the He experience, China’s health ministry is already creating some speed bumps of its own. Last week it drafted guidelines that will force the nation’s scientists to seek approval from authorities before carrying out any risky procedures such as germline editing.

(On March 18 we amended the second paragraph so attribution for the original story was clearer.) 

Deep Dive

Biotechnology and health

Scientists are finding signals of long covid in blood. They could lead to new treatments.

Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.

This baby with a head camera helped teach an AI how kids learn language

A neural network trained on the experiences of a single young child managed to learn one of the core components of language: how to match words to the objects they represent.

The next generation of mRNA vaccines is on its way

Adding a photocopier gene to mRNA vaccines could make them last longer and curb side effects.

Ready, set, grow: These are the biotech plants you can buy now

For $73, I bought genetically modified tomato seeds and a glowing petunia.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.